Our speakers over all four meetings
27-28 April 2023 | Stockholm
The programme for the Nordic Precision Medicine Forum 2024 is currently in production and more speakers will be added in the coming months of 2023.
If you are interested in presenting, please contact Joel Hornby
Keynote and Plenary Speakers from Nordic Precision Medicine Forum and Nordic Oncology Forum earlier in 2023.
Prof. Dr. med. Klaus Pantel
Chairman of the Institute of Tumour Biology at the University Medical Center Hamburg-Eppendorf.
Åslaug Helland
Research Director at the OECI-accredited Oslo Comprehensive Cancer Centre.
Khalid Shah, MS, PhD.
Vice Chairman of Research, Department of Neurosurgery, Brigham and Women’s Hospital
Prof Hans Gelderblom
Heads department of medical oncology at Leiden University Medical Center, Netherlands
All Speakers from Nordic Precision Medicine Forum and Nordic Oncology Forum in 2023.
Abhishek Niroula, Assistant Professor of Data-Driven Precision Medicine and Diagnostics, University of Gothenburg, Sweden
Alexander Eggermont, Professor of Oncological Surgery, General Director of Gustave Roussy, Gustave Roussy Cancer Campus, France
Anders Edsjö, Vice-Chair of GMS management team, Section Head and Senior Molecular Pathologist, Genomic Medicine Sweden (GMS), Sweden
Anders Ekholm, Senior Adviser, Institute for Futures studies, Norway
Anders Stahlberg, Associate Professor, Sahlgrenska Cancer Center, University of Gothenberg, Sweden
Angus Dalgleish, Professor, Oncology & Infection & Immunity, St Georges Hospital, UK
Anikó Kovács, Associate Professor, Chief Doctor Pathologist, Sahlgrenska University Hospital, Sweden
Anna Bodén, MD Consultant Pathologist, Region Östergötland, Sweden
Anna Pasetto, Associate Professor, University of Oslo and Director of the Center for Advanced Cell Therapy (ACT), Cancer Clinic, Oslo University Hospital, Norway
Anne-Marie Vangsted, Executive Vice President, Statens Serum Institut (SSI), Denmark, Denmark
Antonella Cardone, Secretariat, Cancer Patients Europe, Italy
Åslaug Helland, Oncologist, Oslo University Hospital, Norway
Balazs Acs, Senior Postdoctoral Fellow, Karolinska Institutet, Sweden
Begonya Nafria Escalera, Patient Engagement in Research Coordinator, Sant Joan de Déu Research Foundation, Spain
Bettina Lundgren, CEO and Managing Director, Danish National Genome Centre, Denmark
Bettina Ryll, Founder Melanoma Patient Network Europe and Strategist Nollvision cancer, Sweden
Carl Savage, Senior Researcher, Halmstad University, Sweden
Clare Balendran, VP and Head of Translational Development, Novo Nordisk, Denmark
Claudia Pagliari, Director, Global eHealth Group, Centre for Population Health Sciences, The University of Edinburgh, UK
Corrado D’Arrigo, Consultant Histopathologist, Dorset County Hospital Foundation Trust, UK
Daniel Lasserson, Professor of Acute Ambulatory Care, Warwick University and Clinical Lead, Acute Hospital at Home, John Radcliffe Hospital, UK
Daniel Lundqvist, Director of CIR, Centre for Imaging Research, Sweden
Darren Treanor, Director, NPIC and Consultant pathologist, Leeds Teaching Hospitals NHS Trust, UK
Ditte Demontis, Professor, Biomedicine, Aarhus University, Denmark
Ebba Hallersjo Hult, Co-founder and Head of Vision Zero Cancer, Sweden
Ed Schuuring, Professor & Head, Molecular Pathology, University Medical Center Groningen, Netherlands
Elena Netsi, Senior Research Manager, Wellcome’s Mental Health Translation team, UK
Elina Drakvik, Specialist, The Finnish Innovation Fund Sitra, Finland
Emiel Janssen, Professor, Pathology Unit, Stavanger University Hospital, Sweden
Emilia Andersson, Pathologist, oncology lead, Medical & Government Affairs, Roche, Sweden
Eugenia Colón, Head of Breast Pathology Unit, Unilabs-Sweden, Sweden
Frida Lundmark, Policy expert, Lif – the Research Pharmaceutical Companies Association, Sweden
Gal Cafri, Immunotherapy and Genetic Engineering Group leader, Sheba Medical Center, Israel
Georgi Natchev, CEO, Digiburn, Bulgaria
Graham Belfield, Director NGS & Transcriptomics, AstraZeneca, Sweden
Hans Gelderblom, Medical Oncologist, Leiden University Medical Center, Netherlands
Hans van der Vliet, CSO, LAVA therapeutics, Netherlands
Harry Hallock, Senior Researcher, DNV, Norway
Helga Brøgger, Principal researcher, DNV, Norway
Ivan Diaz Padilla, Vice-President, Global Clinical Head, Immuno-Oncology, GSK, Switzerland
Iwona Lugowska, Professor, Head of Precision Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Poland
Janne Lehtiö, Professor, Group Leader, Cancer Proteogenomics, Karolinska Institutet, Sweden
Joakim Börjesson, Director of Digital Health, RISE (Research Institutes of Sweden), Sweden
Joel Hedlund, Data Director CMIV/AIDA, Linköping University, Sweden
Johan Kolmert, Senior Research Scientist, Karolinska Institute, Sweden
Johan Lindberg, Professor of oncology and chief physician, Department of Oncology-Pathology, Karolinska University Hospital, Sweden
Johan Lundin, Research Director, Institute for Molecular Medicine Finland, Professor, Karolinska Institutet, University of Helsinki, Finland
Johanna Bergman, Head of Strategic Initiatives, AI Sweden, Sweden
Johanna Ulfvarson, Professor, Senior adviser, International Coordinator, eHälsomyndigheten, Sweden
Jon Amund Kyte, Group leader, Senior consultant, Oslo University Hospital, Norway
Julie Smith, Senior Lecturer in Medical Laboratory Science, University College Copenhagen, Denmark
Julien Masliah Planchon, Molecular Biologist, Institut Curie, France
Katharina Wassilew, Consultant Histopathologist, Royal Brompton and Harefield Hospitals, Part of Guy’s and St. Thomas’ NHS Foundation Trust, UK
Katriina Peltola, Head Physician, Associate Professor, Clinical Trial Unit, Helsinki Comprehensive Cancer Center, Finland
Khalid Shah, Vice Chair of Research, Brigham and Women’s Hospital, Director, Center for Stem Cell Therapeutics and Imaging, Harvard Medical School, USA
Kjetil Taskén, Professor, Head Institute for Cancer Research, Division of Cancer Medicine, University of Oslo, Norway
Klaus Pantel, Professor of Medicine, Director & Chairman, University Medical Center Hamburg, Germany
Kristian Hveem, Professor in Clinical Epidemiology and Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway
Kristoffer Rohrberg, Head of Phase 1 Unit, Dept. of Oncology, Copenhagen University Hospital – Rigshospitalet, Denmark
Lisa Vervueren, Internal pharmaceutical expert, RIZIV-INAMI, Belgium
Luca Gattinoni, Professor, Director of the Department for Functional Immune Cell Modulation, Regensburg Center for Interventional Immunology, Germany
Luigi de Petri, Senior Consultant, Thoracic Oncology Center, Karolinska University Hospital, Sweden
Malin Johansson, Global Head of Digital Health Strategic Partnerships, Novo Nordisk, Denmark
Margareta Haag, Chairperson, Network Against Cancer, Sweden
Markus Perola, Research Professor, Finnish Institute for Health and Welfare (THL), Finland
Mathias Uhlen, Professor of Microbiology, KTH School of Engineering Sciences in Chemistry, Sweden
Matt Brown, Professor, Chief Scientific Officer, Genomics England, UK
Mattias Rantalainen, Co- founder of Stratipath, and Associate Professor, Karolinska Institutet, Sweden
Maud Kamal, Scientific Manager, Department of Drug Development and Innovation, Institut Curie, France
Maxine Mackintosh, Programme Lead for Diverse Data, Genomics England, UK
Merel Hennink, Patient advocate, Merels World Foundation, Netherlands
Michael Uhlin, Head of the Division of Clinical Immunology, Karolinska University Hospital, Adjunct Professor of Clinical Immunology, Karolinska Institutet, Sweden
Michael Wierer, Director of the Proteomics Research Infrastructure, University of Copenhagen, Denmark
Minetta Liu, Chief Medical Officer of Oncology, Natera, USA
Nasim Farrokhnia, Healthcare Executive, Microsoft Western Europe, Sweden
Nick Guldemond, Professor Healthcare and Public Health, Leiden University Medical Center, Netherlands
Nils-Olav Refsdal, Assistant Director General, Norwegian Ministry of Health and Care Services, Norway
Nina Linder, Associate Professor, Uppsala University and University of Helsinki, FIMM, Finland
Olivia Rekman, Innovation Adviser, AI & Data program, Nordic Innovation (Nordic Council of Ministers), Norway
Päivi Östling, Scientific Lead for Precision Medicine, SciLifeLab and Karolinska Institutet, Sweden
Paul Franks, Head, Dept Translational Medicine and Scientific Director in Medical Science, Novo Nordisk Foundation, Denmark
Paul Frohna, Chief Medical Officer, Imcheck, France
Pekka Ruusuvuori, Assistant Professor, PI in Bioimage informatics Institute of Biomedicine, University of Turku, Finland
Peter Alex, CEO, Beep Insights, Sweden
Peter Asplund, Project Director, MEGALiT, Director Department of Anestethic and Intensive Care, Region Örebro Län, Örebro, Sweden
Peter Kelly, Emergency Physician, Head of Sahlgrenska University Hospital Innovation and Technology Physician Group, Sahlgrenska University Hospital, Sweden
Richard Rosenquist Brandell, Chair of GMS management team, Professor and Senior Physician in Clinical Genetics, Karolinska Institutet, Sweden
Robert Berling, Co-founder and Medical Lead, Beep Insights, Sweden
Ronny Öhman, Senior Physician in Pulmonary Medicine, Skane University Hospital, Sweden
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Pharmacist Medicine & Society, CZ insurance, Netherlands
Sari Pesonen, Co-founder and CSO, Valo Therapeutics, Finland
Sigrid Skånland, Project Group Leader, Lab leader and Researcher, Oslo University Hospital, Sweden
Sigurdis Haraldsdottir, Physician-in-Chief, Medical Oncology, Landspitali University Hospital Associate Professor, University of Iceland, Iceland
Simon Nilsson, Chief Development Officer, Region Gävleborg, Sweden
Siv Andersson, Professor, Uppsala University, Director of Basic Research, Knut and Alice Wallenberg Foundation, Sweden
Stina Wickström, Assistant Professor, Karolinska Institutet, Sweden
Theodoros Foukakis, Associate Professor of Oncology, Senior Consultant, Karolinska Institutet and University Hospital, Sweden
Tobias Sjöblom, Professor, Department of Immunology, Uppsala University, Sweden
Toni Andreu, Scientific Director, EATRIS | European Infrastructure for Translational Medicine, Netherlands
Tzahi Neuman, Senior pathologist, Deputy head, department of diagnostic pathology, The Hebrew University of Jerusalem, Israel
Ulrik Lassen, Clinical Professor, Copenhagen University Hospital, Denmark
Volker Liebenberg, Chief Medical Officer, Elypta, Sweden
Zoher Kapacee, Head of Data and AI, Health Research Authority, UK
Why You Should Join Us in Stockholm
Sponsorship Opportunities
Nordic Precision Medicine Forum offers a unique environment to make new connections, share ideas and formulate partnerships for future collaboration. We work closely with our sponsors to ensure that your objectives are met by building bespoke marketing solutions. So be it a plenary speaking slot, hosting a roundtable or exhibiting at our forum, we ensure you are in front of the right audience.